GLP-1 Dose Escalation Playbook: Week-by-Week Titration

GLP-1 medications work best when you climb the dose ladder slowly. Going too fast is the #1 cause of nausea, dropouts, and gallbladder problems. Here's the standard schedule and how to adjust it.

The universal rule: 4 weeks per step

The label for every modern GLP-1 calls for a minimum of 4 weeks at each dose before escalating (Wegovy PI, Zepbound PI, Ozempic PI, Mounjaro PI). It exists to let your gut adapt. Pushing the dose every 2 weeks because you're "tolerating it fine" is a common mistake — side effects often appear after the third or fourth dose at a new level, not the first.

Wegovy (semaglutide) — weight management

Phase	Week	Dose
Starter	1–4	0.25 mg
Step 2	5–8	0.5 mg
Step 3	9–12	1.0 mg
Step 4	13–16	1.7 mg
Maintenance	17+	2.4 mg

The 1.7 mg step was added specifically because too many patients dropped out at the 1 → 2.4 jump.

Zepbound (tirzepatide) — weight management

Phase	Week	Dose
Starter	1–4	2.5 mg
Step 2	5–8	5 mg
Step 3	9–12	7.5 mg
Step 4	13–16	10 mg
Step 5	17–20	12.5 mg
Maintenance	21+	15 mg

Most patients see strong results at 5 or 10 mg — you don't have to climb all the way unless your clinician advises.

Ozempic / Mounjaro (diabetes-indication dosing)

Ozempic and Mounjaro use lower maintenance doses than their weight-loss siblings:

• Ozempic: 0.25 → 0.5 → 1.0 → 2.0 mg (maintenance often 1.0 or 2.0)
• Mounjaro: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg (matches Zepbound)

If you're using these off-label for weight loss, dosing is at your clinician's discretion — and not all insurance will cover.

Compounded semaglutide / tirzepatide

Compounded versions use the same active ingredients, but formulation, concentration, and dosing instructions can differ by pharmacy and prescriber. If a clinic proposes starting above common starter-dose ranges such as 0.25 mg semaglutide or 2.5 mg tirzepatide, ask the prescriber to document the rationale and confirm the pharmacy concentration.

If your clinic is doing fractional weekly micro-doses, ask why and document the rationale.

When to stay at a dose (skip the escalation)

Hold at the current dose if:

• You're still having moderate nausea, vomiting, reflux, or severe constipation at week 3–4
• You're losing weight at a healthy pace already (0.5–1% of body weight per week)
• You missed doses recently — restart the 4-week clock
• You have a planned medical procedure or pregnancy considerations

It is completely fine to stay at 0.5 mg or 5 mg long-term if it's working. The "maintenance dose" is a ceiling, not a destination.

When to slow down (drop back)

Drop a step if you have:

• Severe persistent nausea or vomiting (especially > 48 hours)
• Signs of dehydration
• New right-upper-quadrant pain (gallbladder)
• Severe heartburn or food sticking
• Inability to eat solid food for more than 2–3 days

Side-effect management →

When to jump (rarely)

Jumping is occasionally appropriate when a patient stopped for a few weeks and is restarting at a previously-tolerated dose. Always under clinician guidance. Solo "I'll just go up early because I plateaued" is a fast way to a gallbladder ER visit.

The plateau question

Plateaus around month 4–6 are normal. The reflex to escalate is often wrong. Talk to your clinician about:

• Diet protein composition (≥ 1.2 g/kg lean body mass)
• Resistance training (preserves lean mass)
• Sleep, stress, alcohol

A higher dose is one lever; it isn't the first one to pull.

Bottom line

Slow titration is one way clinicians try to reduce side effects and dropouts. If a clinic is moving faster than the labeled or commonly used schedule, ask why and confirm the plan with the prescribing clinician.

Find a clinic that follows guideline-based titration →

Sources

• Wegovy prescribing information (Novo Nordisk) — titration schedule
• Zepbound prescribing information (Eli Lilly)
• Ozempic prescribing information
• Mounjaro prescribing information
• STEP-1 trial (NEJM 2021) — Wegovy weight-loss data
• SURMOUNT-1 trial (NEJM 2022) — Zepbound weight-loss data

---

General information, not medical advice. Dose adjustments should always be made with your prescribing clinician.